News Focus
News Focus
icon url

Biobillionair

05/14/20 7:31 AM

#273496 RE: isaeed #273494

Very interesting. Boston & Harvard mentioned but was the “supplement” Vascepa? And gives no details of study....

Great find!

BB
icon url

ilovetech

05/14/20 7:41 AM

#273500 RE: isaeed #273494

isaeed, did you send this to Elisabeth?

ILT
icon url

CaptBeer

05/14/20 8:55 AM

#273512 RE: isaeed #273494

There’s a big difference between “legally obvious” and “Intuitively obvious”, and it’s extremely ironic that while we battle the former in court, the latter is beginning to manifest itself with the SARS-CoV-2 (COVID-19) virus. I’m specifically referring to the RWE (Real World Evidence), that icosapent ethyl may indeed have a positive effect on mitigating the sever conditions of the virus by controlling the “Cytokine Storm”.

I said this weeks ago, and I’ve communicated with IR and Dr. Bhatt and individuals on the Coronavirus Task Force about this. They are being very tight lipped about it for some reason. I suspect they have something up their sleeves???
icon url

Optionsrbest4u

05/14/20 10:05 AM

#273530 RE: isaeed #273494

Resolvins from Omega 3...keep in mind -

This study out of Harvard is potentially tremendously promising for Vascepa...but important to keep in mind that it is possible, for the purposes of cytokine storm mitigation involving COVID-19, that plain old fish oil with the DHA/DPA constituents is superior or equally effective as Vascepa.

Obviously we hope management has been quietly researching Vascepa for this indication and that they will blindside the market before long with an announcement that preliminary research indicates Vascepa is superior to the numerous EPA/DHA supplements already available.